Doesch AO, Zhao L, Gleissner CA, Akhavanpoor M, Rohde D, Okuyucu D, . . . Erbel C. (2014). Inhibition of B7-1 (CD80) by RhuDex® reduces lipopolysaccharide-mediated inflammation in human atherosclerotic lesions. Dove Medical Press.
Chicago Style (17th ed.) CitationDoesch AO, et al. Inhibition of B7-1 (CD80) by RhuDex® Reduces Lipopolysaccharide-mediated Inflammation in Human Atherosclerotic Lesions. Dove Medical Press, 2014.
MLA (9th ed.) CitationDoesch AO, et al. Inhibition of B7-1 (CD80) by RhuDex® Reduces Lipopolysaccharide-mediated Inflammation in Human Atherosclerotic Lesions. Dove Medical Press, 2014.
Warning: These citations may not always be 100% accurate.